tiprankstipranks
Trending News
More News >
Revelation Biosciences (REVB)
NASDAQ:REVB
US Market

Revelation Biosciences (REVB) Income Statement

Compare
185 Followers

Revelation Biosciences Income Statement

Last quarter (Q1 2025), Revelation Biosciences's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q1, Revelation Biosciences's net income was $-2.05M. See Revelation Biosciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 7.97M$ 8.66M$ 10.87M$ 11.95M$ 145.49K
Depreciation and Amortization
$ 27.92K$ 25.05K$ 25.05K$ 16.78K$ 3.80M
EBITDA
$ -7.95M$ -8.63M$ -10.84M$ -11.93M$ -145.00K
Operating Income
$ -7.97M$ -8.66M$ -10.87M$ -11.95M$ -145.00K
Other Income/Expenses
$ -7.06M$ 8.54M$ 34.96K$ -36.35K$ -1.49M
Pretax Income
$ -15.04M$ -120.00K$ -10.83M$ -11.99M$ -1.63M
Net Income
$ -15.04M$ -120.00K$ -10.83M$ -11.99M$ -1.63M
Per Share Metrics
Basic EPS
$ -9.44$ 160.83$ -20.11$ -32.41$ -188.18
Diluted EPS
$ -9.44$ 105.02$ -20.11$ -32.41$ -188.18
Weighted Average Shares Outstanding
1.72M 14.29K 538.50K 369.83K-
Weighted Average Shares Outstanding (Diluted)
1.72M 14.29K 538.50K 369.83K-
Currency in USD

Revelation Biosciences Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis